Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO
08:16pm, Monday, 29'th Jun 2020
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the promotions of Brian R. Mueller to Executive Vice President, Chief Financial Officer and of Andrea L. Acosta to Group Vice President, Chi
BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO
04:16pm, Monday, 29'th Jun 2020
SAN RAFAEL, Calif., June 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced the promotions of Brian R. Mueller to Executive Vice President, Chief Financial Officer an
Inventiva SA Starts U.S. IPO Rollout
03:52pm, Friday, 26'th Jun 2020
Inventiva SA has filed to raise $90 million in a U.S. IPO. The firm is advancing a pipeline of treatment candidates for NASH, MPS and other diseases. IVA is pre
Canaccord Genuity Sticks to Its Buy Rating for Stoke Therapeutics (STOK) - Markets
10:08am, Friday, 26'th Jun 2020
Canaccord Genuity analyst Michelle Gilson reiterated a Buy rating on Stoke Therapeutics (STOK – Research Report) today and set a
Los pacientes con fenilcetonuria piden acceder a más herramientas para mejorar su calidad de vida
08:18am, Friday, 26'th Jun 2020
Con motivo del Día Mundial de la Fenilcetonuria o PKU que se celebra el 28 de junio, la...
Los pacientes con fenilcetonuria piden acceder a más herramientas para mejorar su calidad de vida
08:18am, Friday, 26'th Jun 2020
Con motivo del Día Mundial de la Fenilcetonuria o PKU que se celebra el 28 de junio, la...
Wall Street : fin de séance bullish, les banques US exultent
09:27pm, Thursday, 25'th Jun 2020Wall Street : fin de séance bullish, les banques US exultent
09:20pm, Thursday, 25'th Jun 2020
(CercleFinance.com) - Wall Street s'est envolé au cours de la dernière demi-heure, les acheteurs remportant un bras de fer demeuré longtemps indécis (le Dow Jones était encore dans le rouge vers
Xconomy: CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy
08:21pm, Thursday, 25'th Jun 2020
CSL Behring is joining the chase for a genetic treatment for hemophilia by acquiring a uniQure gene therapy that’s already in late-stage testing. King of
Acquiring Biomarin Would Speed Sanofi Transition to New Therapies
07:26pm, Thursday, 25'th Jun 2020
French pharma giant seeks to exit heart and diabetes research and enter cancer and immune disease Continue reading...
2 police arrested for alleged 'inappropriate' pictures at Wembley murder
06:33pm, Thursday, 25'th Jun 2020
The sisters were repeatedly stabbed to death, and now officers have been arrested for 'sickening' allegations
Acquiring Biomarin Would Speed Sanofi Transition to New Therapies
02:24pm, Thursday, 25'th Jun 2020
Sanofi SA (SNY) has made it clear it wants to get into the rapidly growing gene therapy market, and an acquisition may be the fastest route.
BioMarin's Shares March Higher, Can It Continue?
11:30am, Wednesday, 24'th Jun 2020
As of late, it has definitely been a great time to be an investor in BioMarin Pharmaceutical.
BioMarin's Shares March Higher, Can It Continue?
07:30am, Wednesday, 24'th Jun 2020
As of late, it has definitely been a great time to be an investor in BioMarin Pharmaceutical.
BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference
12:30pm, Tuesday, 23'rd Jun 2020
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide Research & Development and Brian Mueller, Acting Chief Financial Officer, will participate in t
